151 results on '"Beavers, Craig J."'
Search Results
2. Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association
3. JACC: Advances Expert Panel Perspective: Shared Decision-Making in Multidisciplinary Team-Based Cardiovascular Care
4. Antiarrhythmic and Anticoagulant Agents
5. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
6. Management of Iron Deficiency in Heart Failure: Practical Considerations and Implementation of Evidence-Based Iron Supplementation
7. The Role of the Non-Steroidal Mineralocorticoid Antagonist Finerenone in Cardiorenal Management
8. Iron Deficiency in Heart Failure: A Scientific Statement from the Heart Failure Society of America
9. Polypharmacy and Cardiovascular Diseases: Consideration for Older Adults and Women
10. Reply to ‘The pharmacist ally in heart failure: Useful when involved’
11. 2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Solution Set Oversight Committee
12. Leveraging the Cardiovascular Team in Peripheral Artery Disease Diagnosis: A Call to Action.
13. Effective medications can work only in patients who take them: implications for post acute heart failure care
14. Heart Failure Pharmacotherapy Over the Past 30 Years: Boats Against the Current.
15. Selatogrel: A Novel Subcutaneous P2Y12 Inhibitor
16. Oral Anticoagulant Therapy Post-Percutaneous Coronary Intervention
17. ST-Segment Elevation Myocardial Infarction (Lytic Candidate) on Oral Anticoagulant
18. ACS with Bypass Surgery
19. Patient on Oral Anticoagulant Presenting with ACS
20. Defining pharmacist activities in ambulatory heart failure clinics: North American survey and modified Delphi study
21. Best Practice: Using Pharmacist- and Nurse-Led Optimization in Heart Failure to Achieve Guideline Directed Medical Therapy Goals.
22. Effective medications can work only in patients who take them: Implications for post‐acute heart failure care.
23. Pragmatic approach to temporary mechanical circulatory support in acute right ventricular failure
24. Role of Bempedoic Acid in Dyslipidemia Management
25. Still sour about lactic acidosis years later: role of metformin in heart failure
26. Pharmacotherapy Considerations for the Management of Advanced Cardiac Life Support
27. Part I: PSAP Live: Updates from 2022 Book 1 (Cardiology).
28. Meta-Analysis Comparing Carvedilol Versus Metoprolol for the Prevention of Postoperative Atrial Fibrillation Following Coronary Artery Bypass Grafting
29. Management Strategies for Clopidogrel Hypersensitivity
30. BICARBONATE-BASED PURGE SOLUTION DURING IMPELLA SUPPORT: A GROWING ALTERNATIVE
31. Development and application of quality measures of clinical pharmacist services provided in inpatient/acute care settings
32. Optimizing anticoagulation for patients receiving Impella support
33. Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: A Brief Overview
34. Current and future state of clinical pharmacist‐led precision medicine initiatives
35. Guideline-Directed Heart Failure Therapy in Patients after Left Ventricular Assist Device Implantation: A Review
36. Distinguishing Anemia and Iron Deficiency of Heart Failure: Signal for Severity of Disease or Unmet Therapeutic Need?
37. Evaluation of an interactive online information service to improve patient care in the field of anticoagulation and antithrombotic therapy
38. Osocimab: A Novel Agent in Preventing Venous Thromboembolism
39. Key Articles and Guidelines in the Management of Acute Coronary Syndrome and in Percutaneous Coronary Intervention: 2012 Update
40. Selatogrel: A Novel Subcutaneous P2Y12 Inhibitor.
41. Reduced dose thrombolysis with ultrasound-facilitated catheter-directed administration for acute pulmonary embolism reduces length of stay
42. Supplemental Material, APPENDIX_JPP - Use of Glycoprotein IIb/IIIa Inhibitors in the Modern Era of Acute Coronary Syndrome Management: A Survey of Cardiovascular Clinical Pharmacists
43. Erratum to: Management Strategies for Clopidogrel Hypersensitivity
44. Identifying Core Content for Electrocardiogram Instruction in Doctor of Pharmacy Curricula
45. Use of Glycoprotein IIb/IIIa Inhibitors in the Modern Era of Acute Coronary Syndrome Management: A Survey of Cardiovascular Clinical Pharmacists.
46. Use of Glycoprotein IIb/IIIa Inhibitors in the Modern Era of Acute Coronary Syndrome Management: A Survey of Cardiovascular Clinical Pharmacists
47. Use of Alternative Antiplatelet Agents for Clopidogrel Hypersensitivity
48. Reduced dose thrombolysis with ultrasound-facilitated catheter-directed administration for acute pulmonary embolism reduces length of stay.
49. Still sour about lactic acidosis years later: role of metformin in heart failure
50. Cardio-Oncology Drug Interactions: A Primer for Clinicians on Select Cardiotoxic Oncologic Therapies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.